Project Grant HT94252310805
Award Date
8/15/23
Completion Date
8/14/27
Dollars Obligated
$1.1M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Birmingham, AL 35294, USA
Similar Awards
The University of Alabama at Birmingham (UAB) was awarded a $1,485,000.00 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to improve the oncolytic immunovirotherapy of malignant glioma by targeting the glioma secretome. The 3-year grant was awarded on September 30, 2023 and is set to conclude on September 29, 2026. UAB is a public research university known for its innovative and interdisciplinary approach to education, and it...
The University of Alabama at Birmingham (UAB) was awarded a $733,662 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant, awarded on September 1, 2024, supports research to investigate the role of tumor glycans in immune suppression. This federally funded project aims to advance scientific understanding of how specific carbohydrate molecules on tumor cells can inhibit the body's immune response, with the goal of...
The University of Alabama at Birmingham (UAB) received a $1,599,981.00 Project Grant award from the Defense Health Agency on June 1, 2024 under the Military Medical Research and Development program (CFDA 12.420). The grant supports research to activate immune reserves and prevent secondary bacterial lung infections after trauma and hemorrhage. This biomedical research project aims to improve health outcomes for military service members and the broader public. The project will be conducted over a...
The University of Alabama at Birmingham (UAB) was awarded a $2,069,849 Project Grant from the Defense Health Agency under the Military Medical Research and Development federal grant program (CFDA 12.420). The award will support UAB's research from May 1, 2023 to April 30, 2027 to understand cardiovascular disease in mental health and stress disorders. The Military Medical Research and Development program aims to transform military and public health through innovative biomedical research,...
The University of Alabama at Birmingham (UAB) has been awarded a $297,000 Project Grant from the Department of Defense's Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. This grant, awarded on August 1, 2024, will fund research to evaluate the role of Notch signaling in chronic pancreatitis. As a leading research institution, UAB will leverage its expertise in biomedical research to advance scientific understanding and potentially improve treatment...
The University of Alabama at Birmingham (UAB) has been awarded a $740,075 Project Grant from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) to conduct research on "PADI4 as a Driver and Therapeutic Target for Uveal Melanoma Therapy". The award, which runs from September 1, 2024 to August 31, 2027, will support UAB's research into novel therapeutic approaches for treating uveal melanoma, an aggressive form of eye cancer. As a leading research...
The University of Alabama at Birmingham (UAB) was awarded a $2,119,086 Project Grant by the Defense Health Agency (DHA) under the Department of Defense's Military Medical Research and Development program (CFDA 12.420) to conduct research on the Hedgehog pathway in chronic pancreatitis. The 4-year grant, which began on September 30, 2023, aims to advance scientific understanding and develop new therapeutic approaches for this health condition affecting military service members and veterans....
The University of Alabama at Birmingham (UAB) received a $724,115 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420). The purpose of this 3-year grant, awarded on September 1, 2024, is to conduct research on the utility of sodium nitrite in improving recovery after spinal cord injuries. As a leading research institution, UAB will leverage its expertise in biomedical engineering, neuroscience, and clinical trials to...
This Project Grant award of $1,113,750.00 from the Defense Health Agency, under the Military Medical Research and Development program (CFDA 12.420), supports the University of Alabama at Birmingham (UAB) in developing "DUAL CD24/CD276 TARGETING THERAPIES FOR TRIPLE-NEGATIVE BREAST CANCER." The 3-year award, running from August 1, 2023 to July 31, 2026, will fund research to investigate medical solutions for the battlefield and transform health care for service members and the public...
The University of Alabama at Birmingham (UAB) will receive $148,500 through August 31, 2025 to conduct research targeting Schwann cell-mediated cancer progression and metastasis under a Project Grant from the Defense Health Agency. This grant is part of the Military Medical Research and Development program (CFDA 12.420), which supports basic, applied, and advanced biomedical research to improve military and public health through innovative medical solutions. The funding will allow UAB...